Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

What makes a great song? Naturally, a song needs compelling production and sweet melodies, but the most important (and sometimes most underrated) factor is the lyrics. If an artist can tell a ...

The insulin dose given was that which was appropriate clinically for the patient at that time. Only single doses of lente or NPH insulin were given, with no addition of crystalline insulin ...

Looking back at the career of the Grateful Dead bassist, starting with when the band was clean cut and called the Warlocks. Looking back at the career of the Grateful Dead bassist, starting with ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Moving iMage Technologies (NYSE American: MITQ) is a leading provider of technology, products, and services for the Motion Picture Exhibition industry, with expanding ventures into live ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Moving iMage Technologies $MITQ, (NYSE American: MITQ) (“MiT”), a leading technology and services company for cinema ...

Moving iMage Technologies $MITQ, (NYSE American: MITQ) (“MiT”), a leading technology and services company for cinema, Esports, stadiums, arenas and other out-of ...

The global insulin pens market is witnessing unprecedented growth, propelled by the escalating prevalence of diabetes worldwide. According to recent industry reports, the market, valued at USD 35 ...